AGN-151597 (Formerly RST-001) Phase I/II Trial for Advanced Retinitis Pigmentosa

Study Identifier
RST-001-CP-0001
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Protocol
Available Language(s): English
Statistical Analysis Plan
Available Language(s): English
Plain Language Summary
Available Language(s): English

Study Details

Medical Condition
  • Eye Disease
  • Study Drug
  • AGN-151597
  • Phase
    Phase 1/Phase 2
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    All participants in phase 1 and phase 2a had hand motion visual acuity or worse.

    If efficacy was demonstrated from phase 1, better vision subjects could be enrolled; however, efficacy was not demonstrated.

    Study Locations

    Location
    Status
    Location
    University of California San Francisco - Mission Bay /ID# 235717
    San Francisco, California, United States, 94158
    Status
    Not applicable
    Location
    Cincinnati Eye Institute- Edgewood /ID# 236713
    Edgewood, Kentucky, United States, 41017-3415
    Status
    Not applicable
    Location
    Duke Eye Center /ID# 235715
    Durham, North Carolina, United States, 27705
    Status
    Not applicable
    Location
    Retina Foundation of the Southwest /ID# 235199
    Dallas, Texas, United States, 75231
    Status
    Not applicable